| |
 |
|
|
|
|
|
Poster: 160
Visits: 113
Title: MYD88 L265P mutations, but not other variants, identify a subgroup of patients with ABC diffuse large B-cell lymphoma, extranodal involvement and poor outcome
Authors: JORDINA ROVIRA ,
Centre: HOSPITAL CLÍNIC, BARCELONA
|
|
You must be registered to reply or comment.
|
|
MYD88 L265P MUTATIONS, BUT NOT OTHER VARIANTS, IDENTIFY A SUBGROUP OF PATIENTS WITH ABC DIFFUSE LARGE B-CELL LYMPHOMA, EXTRANODAL INVOLVEMENT AND POOR OUTCOME
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|
